Sedia Biosciences Receives WHO Pre-Qualification for its Asanté® HIV-1/2 Oral Fluid Test

BEAVERTON, OR, UNITED STATES, January 13, 2026 /EINPresswire.com/ -- Sedia Biosciences Corporation, a leading developer ...